The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
Hosted on MSN10mon
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug LecanemabThis delay, attributed to procedural issues at the European Medicines Agency (EMA), has implications ... nullify the counsel provided at the SAG-N meeting for lecanemab held on March 11, 2024 ...
Heads of R&D at all major pharma companies have come together to express their concerns about severe disruption to the European Medicines Agency (EMA ... in June at the meeting of the European ...
Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...
The European Medicines Agency (EMA) says its safety committee has begun a review into reports of an association between use of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback